ArticleUrology case reports2026
Neoadjuvant lenvatinib and pembrolizumab for metastatic clear cell renal cell carcinoma: A potential opportunity for complete pathologic and radiographic response.
Eva Kiri Walker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.